Knight Therapeutics Inc (KHTRF) Stock Price & News

Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia

About Knight Therapeutics Inc

CEO-

Employees830

Founded2014

HeadquartersМонреал, Кэбэк, Канад

SectorPharmaceutical industry

Websiteknighttx.com

All values in CAD	2025 оны 9-р сар	2025 оны 12-р сар	2026 оны 3-р сар	2026 оны 6-р сар
Revenue	121.55 сая	133.11 сая	148.44 сая	144.21 сая
Cost of goods sold	65.74 сая	68.38 сая	79.33 сая	74.60 сая
Cost of revenue	65.74 сая	68.38 сая	79.33 сая	74.60 сая
Research and development expenses	8.69 сая	9.22 сая	9.41 сая	10.56 сая
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	31.02 сая	35.45 сая	34.45 сая	36.64 сая
Operating expense	55.16 сая	58.51 сая	58.53 сая	60.66 сая
Total operating expenses	120.90 сая	126.90 сая	137.86 сая	135.25 сая
Operating income	646.00 мян	6.21 сая	10.58 сая	8.96 сая
Other non operating income	-271.00 мян	329.00 мян	4.17 сая	-487.00 мян
EBT including unusual items	-1.92 сая	11.22 сая	14.18 сая	-2.10 сая
EBT excluding unusual items	2.24 сая	1.57 сая	15.50 сая	7.21 сая
Income tax expense	1.87 сая	2.37 сая	1.01 сая	1.26 сая
Effective tax rate	-97.76%	21.12%	7.14%	-59.82%
Other operating expenses	-	-	-	-
Net income	-3.79 сая	8.85 сая	13.17 сая	-3.36 сая
Net profit margin	-3.12%	6.65%	8.87%	-2.33%
Earnings per share	-0.02	0.10	0.14	-0.03
Interest and investment income	1.11 сая	1.22 сая	952.00 мян	901.00 мян
Interest expense	-2.37 сая	-3.92 сая	-2.64 сая	-2.12 сая
Net interest expenses	-1.26 сая	-2.70 сая	-1.69 сая	-1.22 сая
Depreciation and amortization charges	-	-	-	-
EBITDA	18.41 сая	16.47 сая	26.77 сая	23.97 сая
Gain or loss from assets sale	-	-	-	-

Ask anything